Anti-B7-H1 antibodies for treating tumors
US10336823B2 · kind B2 · utility
2Cited by
0References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 11, 2014 |
| Grant date | Jul 2, 2019 |
| Priority date | — |
| Expiry date | Mar 15, 2035 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/70532
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are methods of treating B7-H1-expressing tumors comprising administering an effective amount of MEDI4736 or an antigen-binding fragment thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.